ALX ONCOLOGY HOLDINGS INC Earnings Per Share Diluted

Quick Answer

ALX ONCOLOGY HOLDINGS INC reported Earnings Per Share Diluted of $1.90 (loss) per share for the year ending 2025.

  • ALX ONCOLOGY HOLDINGS INC showed an increase of +26.4% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from ALX ONCOLOGY HOLDINGS INC's annual report (Form 10-K), filed with the SEC on March 9, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), ALX ONCOLOGY HOLDINGS INC's Earnings Per Share Diluted has grown by 8.2%.
  • Historical annual values: Fiscal year 2025: $1.90 (loss) per share | Fiscal year 2024: $2.58 (loss) per share | Fiscal year 2023: $3.74 (loss) per share | Fiscal year 2022: $3.03 (loss) per share | Fiscal year 2021: $2.07 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: